First Patient with Chronic Hepatitis B Dosed with ISA104 in First-in-Human Phase 1 Study
/PRNewswire/ -- ISA Pharmaceuticals B.V., a clinical-stage biotech company developing immunotherapies to treat cancers and serious infectious diseases, is...
Zuid Holland Dave Sprengers Sonja Buschow Erasmus Mc Department Of Gastroenterology Hepatology Liver Unit Of The Erasmus Medical Center Top Sector Life Sciences Health
Source: prnewswire.com